Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 571.00
-13.00 (-2.23%)
Jul 24, 2026, 5:12 PM GMT
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 691.13 million as of July 24, 2026. Its market cap has increased by 70.02% in one year.
Market Cap
691.13M
Enterprise Value
742.35M
Revenue
168.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
571.00
ChartMarket Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 691.13M, an increase of 3,873.44%. That is a compound annual growth rate of 13.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 691.13M | -7.07% |
| Dec 31, 2025 | 743.72M | 67.15% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.43B |
| Oxford Nanopore Technologies | 1.05B |
| Avacta Group | 327.88M |
| PureTech Health | 299.40M |
| Scancell Holdings | 97.55M |
| Faron Pharmaceuticals Oy | 90.86M |
| 4basebio | 81.58M |
| Bioventix | 79.68M |